Table 3

Association between statin use and progression of knee and hip osteoarthritis

Knee osteoarthritisHip osteoarthritis
Progressors, N (%)Adjusted OR95% CIp ValueProgressors, N (%)Adjusted OR95% CIp Value
Non-users288 (7.3)1.00177 (4.5)1.00
Statin users15 (3.0)0.430.25 to 0.770.0121 (4.0)1.100.63 to 1.900.74
Period of statin use (days)
 Non-users346 (7.2)1.00228 (4.8)1.00
 1–11953 (6.3)1.770.71 to 4.440.223 (4.1)1.050.20 to 5.620.95
 120–3643 (2.4)0.300.08 to 1.190.096 (4.8)1.050.38 to 2.880.92
 ≥36518 (4.1)0.490.26 to 0.920.0317 (3.6)1.000.51 to 1.980.92